Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome

被引：23
|
作者：
Selman, Helmy [1 ,2 ]
Brusco, Gian Francesco [1 ]
Fiorini, Fabrizio [2 ]
Barnocchi, Nicoletta [1 ,2 ]
Mariani, Monica [1 ]
El-Danasouri, Imam [3 ]
机构：
[1] Policlin Perugia, Ctr Sterilita & Fecondaz Assistita, I-06121 Perugia, Italy
[2] Primigenia Ctr, Perugia, Italy
[3] IEMA, Chieti, Italy
来源：
FERTILITY AND STERILITY | 2009年 / 91卷 / 04期
关键词：
Cryopreservation; embryo; ovarian hyperstimulation; vitrification; warming; ELECTIVE CRYOPRESERVATION; PREGNANCIES; WOMEN; SUBSEQUENT; PREVENT; BIRTH;
D O I：
10.1016/j.fertnstert.2008.12.027
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
This study aimed to evaluate the efficacy of embryo vitrification as an emergency procedure for patients at high risk of developing ovarian hyperstimulation syndrome (OHSS). A total of 69 embryos, derived from 24 patients for whom embryo transfer could not be performed because of the risk of developing OHSS, were vitrified and warmed for deferred embryo transfer. Surviving embryos were transferred, resulting in 10 clinical pregnancies, of which 4 were successfully delivered and the remaining 6 are still ongoing. (Fertil Steril (R) 2009;91:1611-3. (C) 2009 by American Society for Reproductive Medicine.)
引用
收藏
页码：1611 / 1613
页数：3
相关论文
共 50 条
  • [41] Development of ovarian hyperstimulation syndrome: interrogation of key proteins and biological processes in human follicular fluid of women undergoing in vitro fertilization
    Jarkovska, Karla
    Skalnikova, Helena Kupcova
    Halada, Petr
    Hrabakova, Rita
    Moos, Jiri
    Rezabek, Karel
    Gadher, Suresh Jivan
    Kovarova, Hana
    MOLECULAR HUMAN REPRODUCTION, 2011, 17 (11) : 679 - 692
  • [42] NUMBER OF FOLLICLES, OOCYTES AND EMBRYOS IN HUMAN IN-VITRO FERTILIZATION IS RELATIVE TO SERUM ESTRADIOL AND PROGESTERONE PATTERNS DURING DIFFERENT TYPES OF OVARIAN HYPERSTIMULATION
    SUCHANEK, E
    HUDERER, K
    DOBEC, D
    HLAVATI, V
    SIMUNIC, V
    GRIZELJ, V
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1994, 56 (02): : 121 - 127
  • [43] Intravenous albumin prophylaxis in high risk patients for moderate to severe ovarian hyperstimulation syndrome.
    Kumbak, B
    Kahraman, S
    Karlikaya, G
    Karagozoglu, H
    Sen, T
    Hatirnaz, S
    FERTILITY AND STERILITY, 2005, 84 : S264 - S264
  • [44] Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome
    Lainas, G. T.
    Lainas, T. G.
    Venetis, C. A.
    Sfontouris, I. A.
    Zorzovilis, I. Z.
    Alexopoulou, E.
    Tarlatzis, B. C.
    Kolibianakis, E. M.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2018, 51 (01) : 126 - 133
  • [45] The use of laparoscopic ovarian electrocautery in preventing cancellation of in-vitro fertilization treatment cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries
    Rimington, MR
    Walker, SM
    Shaw, RW
    HUMAN REPRODUCTION, 1997, 12 (07) : 1443 - 1447
  • [46] Coasting decreases ovarian hyperstimulation syndrome in patients at risk. Is the quality of oocytes, embryos and pregnancy rate the price to pay?
    Grace, J
    Rizk, B
    Mulekar, M
    FERTILITY AND STERILITY, 2005, 84 : S300 - S300
  • [47] Elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome may not prevent the condition but reduces the live birth rate
    Awonuga, AO
    Pittrof, RJ
    Zaidi, J
    Dean, N
    Jacobs, HS
    Tan, SL
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1996, 13 (05) : 401 - 406
  • [48] Different Baseline Levels of Angiogenesis Related Cytokines in Serum of PCOS Patients With and Without Ovarian Hyperstimulation Syndrome Undergoing in Vitro Fertilization
    Hou, Zhen
    Tal, Reshef
    Wu, Chunxiang
    Mao, Yundong
    Liu, Jiayin
    JOURNAL OF REPRODUCTIVE MEDICINE, 2019, 64 (11-12) : 425 - 431
  • [49] GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles
    Zhai, Xiang-Hong
    Zhang, Ping
    Wu, Feng-Xia
    Wang, An-Cong
    Liu, Pei-Shu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (06) : 3097 - 3102
  • [50] High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization
    de Jong, D
    Macklon, NS
    Mannaerts, BMJL
    Bennink, HJTC
    Fauser, BCJM
    HUMAN REPRODUCTION, 1998, 13 (03) : 573 - 575
12345